5 Galaxy Z Fold 8 features iPhone 18 Ultra will struggle to top This week, Samsung announced a new addition to its foldable family, the Galaxy Z Fold 8, and so far, it looks like a very impressive device. It should be very competitive with Apple's still-unannounced iPhone Fold Ultra, which is rumored to have a similar design.The...

There has been talk of "rescheduling" cannabis for years, a regulatory move that would significantly ease federal restrictions on the drug. Now, with a recent push from the White House to expedite the rescheduling process, we may see that change come to pass. Moving cannabis to Schedule III a less-restrictive classification for drugs would represent a very important shift in how the federal government treats cannabis research, in that it would officially state that cannabis has medical use. This landmark decision would encourage some of the largest scientific investment in cannabis research to date and help build some of the strongest evidence of the value of cannabis-based therapies.However, the move to Schedule III should be viewed as a transition rather than an endpoint. How cannabis is regulated, todayCannabis has existed in a complicated space in medicine, policy and public perception for decades.More than 6 million Americans are registered to use cannabis through state medical programs. Clinicians participating in state medical cannabis programs generally "certify" and "recommend" specific cannabis products to certain patients, rather than write traditional prescriptions. Additionally, a handful of cannabis-derived and cannabinoid-based medications have received formal Food and Drug Administration (FDA) approval. However, since the Controlled Substances Act was enacted in 1970, cannabis has been classified as a Schedule I substance. This category is associated with the highest level of restriction, including substances such as heroin, MDMA, and LSD.Under federal law, Schedule I drugs are defined as having a high potential for abuse and no currently accepted medical use. Given some cannabis-derived drugs are FDA approved, it may seem contradictory that cannabis remains a Schedule I substance. The key is that federal drug scheduling, FDA drug approval and state cannabis laws are separate legal and regulatory systems.Federal law classifies cannabis as a Schedule I drug. Separately, the FDA evaluates and approves individual cannabinoid medications for specific medical conditions. Independently, states can authorize cannabis for medical or adult use under their own laws, even though cannabis remains illegal under federal law. This three-tiered regulatory landscape can be confusing for patients, clinicians and the general public alike.Federal law currently classifies cannabis as a Schedule I drug. (Image credit: Martin Deja via Getty Images)Rescheduling would be a boon for researchFor a few years, federal officials have recommended moving cannabis to Schedule III, which includes drugs with accepted medical uses that are subject to fewer federal restrictions. Ketamine and anabolic steroids, like testosterone, are examples. Compared with Schedule I substances, Schedule III drugs are considered to have a lower potential for abuse and can be prescribed for accepted medical uses under federal law.Rescheduling cannabis would thus create a regulatory environment that's more favorable to research, which could support the development of future FDA-approved cannabis-based medicines. Researchers are already exploring cannabinoids as potential treatments for conditions including chronic pain, post-traumatic stress disorder, inflammatory bowel disease and sleep disorders, but the available evidence remains limited for many uses. Evidence is limited, in part, because for decades researchers studying cannabis have faced regulatory hurdles that extend beyond those encountered with many other controlled substances. Studies using cannabis often require additional federal, institutional and local approvals, compared to research with less-restricted drugs. They have extra requirements around securely storing and handling cannabis. They require detailed record-keeping to document how research materials are received, stored and used, as well as Drug Enforcement Administration registration for the principal investigator conducting Schedule I research.Additionally, federal restrictions have historically limited researchers' access to cannabis products that reflect those people regularly use, such as commercially available flower, vape products and edible formulations. This regulatory burden has historically discouraged some universities, healthcare systems and funding organizations from investing in cannabis research. These hurdles have made cannabis studies slower, more costly and smaller in scale than those conducted with more loosely controlled drugs.Federal restrictions have historically limited researchers' access to cannabis products that reflect those people regularly use, such as commercially available flower, vape products and edible formulations. Shifting cannabis to Schedule III would help to reduce these barriers, opening opportunities for more universities and healthcare systems to conduct much-needed clinical studies for medical cannabis. It could help researchers conduct the larger, more rigorous clinical trials needed to determine which therapies are truly safe and effective and which are not.Such gold-standard studies would better evaluate cannabis' potential benefits and risks, as well its effects in specific medical conditions and appropriate dosing for each. This evidence could, in turn, help reduce the stigma associated with cannabis use.What rescheduling won't accomplishRescheduling cannabis will not automatically make cannabis more accessible to patients or immediately establish where cannabis is beneficial, what doses are most appropriate or which patients are most likely to benefit. It would not automatically convert existing state cannabis programs into the conventional prescription model used for most Schedule III drugs. And it would not immediately resolve the complexities surrounding state medical cannabis programs, which operate outside the traditional FDA-approved medication pathway.Unlike most prescription drugs, medical cannabis is an umbrella term that includes hundreds of products that differ in cannabinoid content, formulation, dose and route of administration. Most of those products have not been approved by the FDA, so rescheduling would not automatically place them into the traditional prescription drug system or immediately resolve many of the financial and access barriers patients face when trying to use them.Related storiesCould cannabis treat cancer someday? Here's what the science says so farCBD reportedly discovered in plant that's not cannabisGenetic risks behind 'cannabis use disorder' found in huge studyWithout robust follow-up research, rescheduling alone would do little to resolve the uncertainty surrounding many cannabis products. In short, the greatest benefit of moving cannabis to Schedule III would not be the policy change itself; it would be the opportunity to build a stronger evidence base for cannabis science and medicine. Policymakers may open the door to Schedule III, but researchers, clinicians and regulatory agencies will determine whether this opportunity will actually lead to the appropriate and meaningful advances in cannabis science and medicine.The value of rescheduling will be measured not by how quickly it changes patients' access to cannabis, but by whether it helps create the scientific foundation needed to guide responsible medical use.This article is for informational purposes only and is not meant to offer medical advice.Opinion on Live Science gives you insight on the most important issues in science that affect you and the world around you today, written by experts and leading scientists in their field.

Hell Let Loose Vietnam is opening up for a crossplay playtest this weekend, giving PC and console players a chance to go at it in the 50v50 ultra-tactical milsim for free - and on a new map, no less. This open playtest is the first time crossplay has been enabled in HLL:V, and the new [...]

til you can make the process more efficient and lucrative. Once relegated to the dark corners of Itch.io and Kongregate, the genre has grown in popularity in recent years, and marketplaces like Steam are bursting at the seams with new idle, clicker, and incremental games for you to try. Luckily, you have us to help you find the best clicker games worth playing. The very best ones manage to distill high-complexity concepts into a series of single clicks and automation, and while they might not be known for their depth or storylines, they can be incredibly relaxing to play for hours on end.

Disney est aussi prsent la Comic Con de San Diego. Lors de son panel, la firme de Birbank a dvoil le premier teaser trailer pour l'une de ses sries les plus attendues de l'anne.

En vue de sa sortie ce 28 juillet 2026, Halo Campaign Evolved entend accompagner l'vnement en se fendant d'un tas de contenus gratuits offerts aux joueurs.

Lensemble des joueurs Xbox Series peuvent donc dcouvrir trois nouveaux jeux ce weekend, avec en supplment deux jeux rcents bonus pour les membres du Xbox Game Pass.

La srie Blade Runner de Prime Video dvoile de nouvelles images la Comic Con de San Diego. Dcouvrez enfin Michelle Yeoh et Hunter Schafer en costumes.

Advertisement Landmark Bird Report to Launch in Nairobi Ahead of Global Flyways SummitNairobi will host the launch of the latest State of the Worlds Birds Report on 11 September 2026. Published every four years by BirdLife International, the report focuses on migratory bird populations. It will also guide global conservation efforts across the worlds major flyways.The report will launch during the Global Flyways Summit. The event will bring together governments, scientists, conservation organisations, Indigenous Peoples, local communities and development partners. Together, they will explore ways to strengthen international cooperation on bird conservation.A Global Health Check for Migratory BirdsMigratory birds travel thousands of kilometres every year. In doing so, they connect ecosystems, communities and economies across continents. As a result, they remain important indicators of environmental health.The report draws on BirdLife Internationals scientific data and global expertise. It assesses population trends, extinction risks and the condition of habitats birds depend on throughout their annual journeys.In addition, the report highlights growing threats to migratory species. These include habitat loss, environmental degradation and increasing pressure on migratory shorebirds. Today, shorebirds rank among the worlds most threatened bird groups.Every wetland, forest and feeding ground along a flyway plays a critical role. If one site disappears, migration becomes more difficult. Consequently, bird populations become more vulnerable.For this reason, the report examines the health of Key Biodiversity Areas and other important habitats across major flyways. It also reinforces the need for countries to work together since migratory birds cross many borders each year.Turning Science into ActionBirdLife International and Nature Kenya will co-host the Global Flyways Summit. During the event, delegates will adopt the Nairobi Flyways Declaration. The declaration will draw directly from the reports findings.Furthermore, it will encourage governments, conservation organizations, financial institutions and development partners to commit to practical policy, conservation and financing actions.Together, the report and declaration aim to transform scientific evidence into measurable conservation outcomes.Landmark Bird Report to Launch in Nairobi Ahead of Global Flyways SummitGlobal Leaders Call for CollaborationBirdLife International Chief Executive Officer Martin Harper said the report offers one of the most comprehensive assessments of migratory birds. He added that it also identifies solutions already delivering positive results.Migratory birds connect countries, continents and cultures through some of the most remarkable journeys in the natural world. This edition of the State of the Worlds Birds will provide an authoritative assessment of how these species are faring and where action is most urgently needed. Just as importantly, it will highlight solutions that are already making a difference.Harper noted that bringing global conservation leaders together in Nairobi creates an opportunity to strengthen international commitments through science-based action.Kenyas Strategic PositionKenya lies along the African-Eurasian Flyway, one of the worlds most important migration routes. The corridor connects Africa, Europe and Asia. Moreover, Kenyas wetlands, lakes and coastline provide essential feeding and resting sites for millions of birds every year.Nature Kenya Executive Director Dr. Paul Matiku said the summit highlights Africas growing leadership in biodiversity conservation.As a country situated along the African-Eurasian Flyway, we see first-hand the importance of international cooperation in conserving migratory species. The Global Flyways Summit provides an opportunity for Africa to help lead a global response informed by science and focused on delivering tangible commitments for birds, biodiversity and people.Meanwhile, senior representatives from the Government of Kenya, international institutions and the global conservation community are expected to attend. Her Imperial Highness Princess Takamado of Japan, Global Ambassador and President of BirdLife International, will also participate alongside other international conservation leaders.Ultimately, the launch positions Nairobi at the centre of global discussions on biodiversity and conservation. It also reinforces Kenyas role in protecting migratory birds and the ecosystems that sustain them.Read more about the summit on hereThe post Landmark Bird Report to Launch in Nairobi Ahead of Global Flyways Summit appeared first on Africa Business News.

Magnet Wire is an electrically insulated copper or aluminum wire primarily used in motors, transformers, generators, inductors, and other electromagnetic equipment. It plays a crucial role in improving electrical efficiency, power transmission, and energy conversion across industries such as automotive, industrial manufacturing, consumer electronics, and renewable energy. According to the...